Related Experiment Video
Updated: Sep 29, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency
Toshihiko Mori1, Kazushige Nagai, Michio Mori
1Department of Pediatrics, Otaru Kyokai Hospital, 1-6-15 Suminoe, Otaru, Hokkaido 047-8510, Japan. toshihiko_mori@smc.mhc.east.ntt.co.jp
Abstract:
A 4-month-old boy, with late-onset argininosuccinate lyase (ASL) deficiency with hepatomegaly, was treated by protein restricted diet and arginine supplementation; he was followed for 3 years. Hepatomegaly and mild liver dysfunction persisted without significant hyperammonemia. He maintained normal psychomotor development to the age of 12 months, but, at 3 years of age, his developmental status is in the borderline normal range. Liver biopsy performed at 12 months of age demonstrated swollen and pale hepatocytes with abnormal glycogen deposition and mild periportal fibrosis. A subsequent liver biopsy at 3 years of age showed progressive liver fibrosis in the periportal and central areas, which extended into the liver lobule. These findings suggest that liver impairment in ASL deficiency may advance without significant hyperammonemia and underline the importance of repeated liver biopsy in this disorder, even when the plasma ammonia level is well controlled.
Related Concept Videos
Cirrhosis II: Pathophysiology
Lysosomal Hydrolases
Cirrhosis I: Introduction
Chronic Pancreatitis II: Pathophysiology
Urea Cycle
